Admission Date:  [**2178-7-28**]              Discharge Date:   [**2178-8-7**]  Date of Birth:  [**2125-5-12**]             Sex:   F  Service: MEDICINE  Allergies: Patient recorded as having No Known Allergies to Drugs  Attending:[**First Name3 (LF) 2297**] Chief Complaint: PNA  Major Surgical or Invasive Procedure: bronchoscopy c stent removal  History of Present Illness: Ms. [**Known lastname 5395**] is a 53 year-old female with a recent diagnosis of non-small cell lung cancer who admitted to OSH on [**7-27**] for dyspnea for 1-2 days PTA.
At OSH, she was found to have PNA and there was concern about a possible stent obstruction so she was transferred to BICMC on [**7-29**] for urgent bronchscopy and stent evaluation.
On [**7-29**] she underwent rigid bronchoscopy and it was found that her y-stent migrated so it was removed was removed.
She was intubated for the procedure and it was decided to keep the patient ventillated post-bronch given the severity of her PNA.
Currently, she has been mildly hypotensive this morning, but is currently off pressors thought to be secondary to a medication effect.
She is intubated and sedated and appears comfortable.
Review of systems: unable to obtain [**12-22**] sedation .
Past Medical History: # NSCLC - Received her first cycle of carboplatin and Taxol chemotherapy [**2178-7-9**] & Silicone Y-stent placed [**2178-7-4**] # tracheal stent placement # SVC obstruction on CT scan # GERD  Social History: per records TOB: [**11-21**] PPD for 20 years.
A-line in place and 2 PIVs.
stent culture [**7-29**]: WOUND CULTURE (Final [**2178-8-2**]):       Due to mixed bacterial types (>=3) an abbreviated workup is       performed; P.aeruginosa, S.aureus and beta strep.
BETA STREPTOCOCCI, NOT GROUP A.     FUNGAL CULTURE (Preliminary):       [**Female First Name (un) **] ALBICANS.
POTASSIUM HYDROXIDE PREPARATION (Final [**2178-7-29**]):       TEST CANCELLED, PATIENT CREDITED.
This is a low yield procedure based on our in-house studies if       pulmonary Histoplasmosis, Coccidioidomycosis, Blastomycosis,       Aspergillosis or Mucormycosis is strongly suspected, contact the       Microbiology Laboratory (7-2306).
Brief Hospital Course: This is a 53 yo with recent diagnosis of NSCLC who presented to OSH with pneumonia she is s/p y-stent removal at [**Hospital1 18**] and is being transferred to the ICU team for further management as unable to extubate after stent removal.
# Respiratory failure - Per the pulmonary team, the patient was intubated for airway protection in preparation for her bronchoscopy and stent removal, new stent could not be placed [**12-22**] anatomy.
Pt was maintained on mechanical ventilation in AC mode at ARDSnet settings.
Pt required sedation with midazolam and fentanyl in order to remain synchronous c the vent.
Pt's prognosis was felt to be very poor and family ultimately felt that pt would not have wanted to remain intubated and pt was transitioned to CMO on [**2178-8-8**].
Pt received fluid boluses to maintain MAP>65.
Sedation was also kept at the minimum level required for pt to be synchronous c ventilator.
Pt had been on decadron at home and then pulsed c hydrocortisone 100 q8h at OSH.
Given her home steroid usage, concerned for both typical pneumonia organisms as well as opportunistic infections.
Pt was initially placed on zosyn, cipro, vancomycin and fluconazole and cultures sent from BAL and [**Date Range **].
ID consult was called and the recommendation was made to switch from fluconazole to micafungin out of concern for fungal pna.
All meds were discontinued on [**2178-8-8**] when pt became CMO.
cell: [**Telephone/Fax (1) 82566**]   Medications on Admission: HOME MEDS Decadron 8mg PO BID Klonopin 0.5 mg PO QHS Percocet-dose unknown Mucinex -dose unknown  MEDS ON TRANSFER FROM OSH # Fluconazole 400 mg PO Q24H # Heparin 5000 UNIT SC TID # Hydrocortisone Na Succ.
100 mg IV Q8H # Insulin SC # Albuterol Inhaler [**2-23**] PUFF IH Q4H:PRN wheezing # Pantoprazole 40 mg IV Q24H # Chlorhexidine Gluconate 0.12% Oral Rinse 15 ml ORAL [**Hospital1 **] # Piperacillin-Tazobactam 4.5 g IV Q6H # Ciprofloxacin 200 mg IV ONCE # Propofol 20-50 mcg/kg/min IV DRIP TITRATE TO sedation # Ciprofloxacin 400 mg IV Q12H # Clonazepam 0.5 mg PO QHS # Docusate Sodium 100 mg PO BID # Vancomycin 1000 mg IV Q 12H # Fentanyl Citrate 25-100 mcg/hr IV DRIP INFUSION  Discharge Medications:   Discharge Disposition: Expired  Discharge Diagnosis:   Discharge Condition:    Completed by:[**2178-8-7**
